Massachusetts-based device maker Alere (NYSE:ALR) said in its quarterly earnings call that it’ll shed some of its business units in order to reorganize in the wake of a missed quarter.
Alere
Shake-up at Alere: Top execs step down, including CEO Ron Zwanziger
Bay State device maker Alere is undergoing a major shakeup as CEO Ron Zwanziger stepped down alongside a pair of high-ranking members from staff, moves that the company called part of the "ongoing review of its strategy and operations."
Medtech personnel moves for the week of Mar. 10, 2014
ConMed proxy war gets ugly
February 28, 2014 by Brad Perriello
The proxy war over control of the board at ConMed turned ugly this week after serious allegations surfaced against 1 of the medical device company’s nominees for director.
ConMed proxy war gets ugly
Remote patient monitoring: Alere’s MobileLink wins 510(k)
Following a regulatory win in the U.S., recently re-branded Alere, formerly MedApps, said it will roll out its 1st cloud-based remote patient monitoring device later this year.
Details emerge on Medtronic’s spinal business layoffs | MassDevice.com On Call
BG Medicine puts a new man in the corner office | Personnel Moves
Eric Bouvier took over the corner office at BG Medicine (NSDQ:BGMD) yesterday as president & CEO of the Waltham, Mass.-based diagnostics developer.
Prior to joining BG, Bouvier, 51, headed the Immunoassay business at global diagnostics company BioMérieux. He also held the role of president & CEO of BioMérieux’s U.S. subsidiary bioMerieux Inc.
Orsinger alights with $52M golden parachute from Synthes sale | Acquisitions Roundup
Synthes CEO Michel Orsinger will land a $52 million payout to give up the corner office as part of the Swiss orthopedic device maker’s $21.3 billion buyout by med-tech titan Johnson & Johnson (NYSE:JNJ).
The deal, slated to close in early 2012, includes a $51.9 million payout to Orsinger for leaving Synthes and a multimillion-dollar stock package for his new position with Johnson & Johnson.
Getinge Group pays $680 million for Atrium Medical | Acquisitions Roundup
Sweden-based Getinge Group announced a definitive agreement to acquire soft tissue reinforcement technology developer Atrium Medical for $680 million.
Atrium will operate as an independent, self-contained unit of Getinge subsidiary Maquet Cardiovascular and will continue to be led by current Atrium president, Trevor Carlton, according to a press release.
Alere won’t take no for an answer | Acquisitions Roundup
After a firm rejection of its buyout offer, Alere Inc. (NYSE:ALR) has started pleading to the sensibilities of Scottish competitor Axis-Sheild’s shareholders. This is not the first time the two firms have traded statements since Alere first offered its buyout in June.
Axis-Shield still a firm no
Axis-Shield plc (“Axis-Shield” or the “Company”)
Response to Statement by Alere AS Holdings Limited (“Alere”), a wholly-owned subsidiary of Alere Inc.
The Board of Axis-Shield (the “Board”) notes today’s announcement released by Alere reiterating its unsolicited offer of 460 pence per share (the “Offer”).
The Board of Axis-Shield is disappointed that Alere has not taken notice of the firm rebuttal from shareholders to its wholly inadequate offer, made clear by the less than 1 per cent. level of acceptances it previously received as disclosed in Alere’s announcement of 16 September 2011.